Heart disease is the number one cause of death today with aortic valve stenosis (AVS) being a major contributor to the mortality rate1. Because of the invasive nature of Aortic Valve Resection (AVR), the typical treatment for AVS, between 30–60% of patients affected by severe aortic stenosis cannot be treated surgically, usually due to age and advanced comorbidities. Qualifying individuals must undergo extensive rehabilitation and of those who qualify 4.3% to 25% do not survive the first year following the procedure3,4.
- Bioengineering Division
In Vitro Beating Heart Simulator for Minimally Invasive Heart Valve Therapy Research
- Views Icon Views
- Share Icon Share
- Search Site
Gogarty, MB, & Dasi, LP. "In Vitro Beating Heart Simulator for Minimally Invasive Heart Valve Therapy Research." Proceedings of the ASME 2012 Summer Bioengineering Conference. ASME 2012 Summer Bioengineering Conference, Parts A and B. Fajardo, Puerto Rico, USA. June 20–23, 2012. pp. 573-574. ASME. https://doi.org/10.1115/SBC2012-80743
Download citation file: